Stay up-to-date with our latest news, blog articles, videos, and event announcements. Learn from business success stories and gain access to valuable e-books and resources.
Why small-molecule development risk is often discovered too late Small-molecule development does not usually fail because teams lack effort. It fails because risk is discovered too late. The cost then appears as rework, delayed approvals, or supply plans that collapse […]
In small-molecule development, risk rarely appears as a single obvious event. It usually emerges through an atypical analytical result that cannot be defended, a stability trend that forces reformulation, a tech transfer that loses process intent, or an HPAPI handling gap that […]
Optimizing fill–finish for biologics begins at a point where resources are constrained, knowledge is incomplete, and regulatory scrutiny is intense. The central task is to convert a promising molecule into a phase-appropriate, manufacturable dosage form that is safe, stable, and clinically usable—often […]
In the high-stakes world of small-molecule development, the transition from pre-clinical “garage-style” synthesis to a scalable, GMP-ready clinical candidate is where most asset valuations either soar or plummet. For small and mid-sized pharma companies, this is not just a technical hurdle, it is a […]
It has been three years since our Kawagoe site became part of the Adragos family, and it is a milestone that fills me and our entire team with immense pride. This journey has been one of transformation, growth, and partnership. […]
Adragos Pharma is pleased to announce its participation in DCAT Week 2026, taking place in New York City from March 23-26th. As a global Contract Development and Manufacturing Organization (CDMO), we look forward to engaging with industry leaders, partners, and […]
Get notified on our latest news.
